The impact of multifocal perineural invasion in predicting survival in patients with oral squamous cell carcinoma: A multicenter investigation

被引：3
|
作者：
Hasmat, Shaheen [1 ,2 ,9 ]
Heller, Gillian [2 ]
Cook, Lachlan [3 ,4 ,5 ]
Gupta, Ruta [1 ,2 ,6 ]
Clark, Jonathan R. [1 ,2 ,7 ]
Ooi, Eng H. [3 ,4 ,5 ]
Low, Tsu-Hui [1 ,2 ,8 ]
机构：
[1] Univ Sydney, Fac Med & Hlth, Cent Clin Sch, Sydney, NSW, Australia
[2] Sydney Head & Neck Canc Inst, Chris OBrien Lifehouse, Camperdown, NSW, Australia
[3] Flinders Med Ctr, Dept Otolaryngol Head & Neck Surg, Adelaide, SA, Australia
[4] Royal Adelaide Hosp, Adelaide, SA, Australia
[5] Flinders Univ S Australia, Coll Med & Publ Hlth, Dept Surg, Bedford Pk, SA, Australia
[6] Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, NSW Hlth Pathol, Sydney, NSW, Australia
[7] Sydney Local Hlth Dist, Royal Prince Alfred Inst Acad Surg, Sydney, NSW, Australia
[8] Macquarie Univ, Fac Med & Hlth Sci, Dept Otolaryngol Head & Neck Surg, Sydney, NSW, Australia
[9] Sydney Head & Neck Canc Inst, Chris OBrien Lifehouse, 119-143 Missenden Rd, Camperdown, NSW 2050, Australia
来源：
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2023年 / 45卷 / 10期
关键词：
AJCC; oral cancer; perineural invasion; squamous cell carcinoma; survival; AMERICAN JOINT COMMITTEE; PROGNOSTIC IMPACT; CANCER; DEPTH;
D O I：
10.1002/hed.27485
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
BackgroundPerineural invasion (PNI) in oral squamous cell carcinoma (OSCC) does not contribute to the current American Joint Committee on Cancer 8th edition (AJCC8) staging manual. This study seeks to validate the effect of multifocal PNI in a large cohort of patients. MethodsPatients undergoing primary surgical treatment of OSCC with curative intent between 1995 and 2022 was retrieved from two Australian head and neck databases. PNI was categorized as a single focus or multiple foci. Study end points included disease-specific survival (DSS) and overall survival (OS). ResultsComplete data for survival analysis was available in 993 patients. Multifocal PNI was associated with a 61% increased risk of death due to OSCC (HR 1.61, 95% CI 1.11-2.33, p = 0.014) and a 32% increased risk of death from any cause (HR 1.32, 95% CI 1.01-1.73, p = 0.045). ConclusionsMultifocal PNI is a significant predictor of survival in OSCC.
引用
收藏
页码：2605 / 2612
页数：8
相关论文
共 50 条
  • [31] Interobserver Variation Among Pathologists in Evaluating Perineural Invasion for Oral Squamous Cell Carcinoma
    Chi A.C.
    Katabi N.
    Chen H.-S.
    Cheng Y.-S.L.
    Head and Neck Pathology, 2016, 10 (4) : 451 - 464
  • [32] Impact of Perineural Invasion and Preexisting Type 2 Diabetes on Patients with Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy
    Su, Nai-Wen
    Mok, Lai-Man
    Chan, Mei-Lin
    Liu, Hung-Chang
    Chang, Wei-Chin
    Yun, Chun-Ho
    Shieh, Tze-Yu
    Wu, Ming-Che
    Lin, Huan-Chau
    Huang, Wen-Chien
    Chen, Yu-Jen
    CANCERS, 2023, 15 (04)
  • [33] Perineural Invasion in Squamous Cell Carcinoma of the Oral Cavity: Histology, Tumor Stage, and Outcome
    Laske, Roman D.
    Scholz, Irene
    Ikenberg, Kristian
    Meerwein, Christian
    Vital, Domenic G.
    Studer, Gabriela
    Rossle, Matthias
    Huber, Gerhard F.
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2016, 1 (01): : 13 - 18
  • [34] Grading systems and perineural invasion in oral squamous cell carcinoma - a disease-specific survival analysis
    de Aquino, Sibele Nascimento
    de Souza, Lucas Lacerda
    Alvarenga, Daniel
    Bonan, Paulo Rogerio Ferreti
    Martins, Helder Domiciano Dantas
    Verner, Francielle Silvestre
    Lopes, Marcio Ajudarte
    Vargas, Pablo Agustin
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2025, 30 (02): : e247 - e255
  • [35] Prognosis of oral squamous cell carcinoma with perineural invasion: A comparative study of classification types
    Park, Jae
    Megow, Anna
    Swalling, Adam
    Hodge, John-Charles
    Foreman, Andrew
    Boase, Samuel
    Valentine, Rowan
    Krishnan, Suren
    Ooi, Eng H.
    CLINICAL OTOLARYNGOLOGY, 2020, 45 (01) : 99 - 105
  • [36] Redefining Perineural Invasion in Head and Neck Cutaneous Squamous Cell Carcinoma
    Cohen, Erin R.
    Misztal, Carly
    Dable, Cortney
    Gomez-Fernandez, Carmen
    Bhatia, Rita G.
    Roth, Patrick
    Ma, Ruixuan
    Trosman, Samuel
    Green, Carlos
    Nicolli, Elizabeth
    Dinh, Christine T.
    Sargi, Zoukaa B.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2022, 167 (04) : 705 - 715
  • [37] A clinicopathological study of perineural invasion and vascular invasion in oral tongue squamous cell carcinoma
    Matsushita, Y.
    Yanamoto, S.
    Takahashi, H.
    Yamada, S.
    Naruse, T.
    Sakamoto, Y.
    Ikeda, H.
    Shiraishi, T.
    Fujita, S.
    Ikeda, T.
    Asahina, I.
    Umeda, M.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2015, 44 (05) : 543 - 548
  • [38] Preoperative Prediction of Perineural Invasion in Oesophageal Squamous Cell Carcinoma Based on CT Radiomics Nomogram: A Multicenter Study
    Zhou, Hui
    Zhou, Jianwen
    Qin, Cai
    Tian, Qi
    Zhou, Siyu
    Qin, Yihan
    Wu, Yutao
    Shi, Jian
    Feng, Feng
    ACADEMIC RADIOLOGY, 2024, 31 (04) : 1355 - 1366
  • [39] Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma
    Chen, Tseng-Cheng
    Chang, Huei-Lun
    Yang, Tsung-Lin
    Lou, Pei-Jen
    Chang, Yih-Leong
    Ko, Jenq-Yuh
    Wang, Cheng-Ping
    ORAL ONCOLOGY, 2019, 97 : 1 - 6
  • [40] Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients
    Holcomb, Andrew J.
    Farrokhian, Nathan
    Tolan, Claire
    Whiteford, Erin
    Villwock, Mark
    Kakarala, Kiran
    Shnayder, Yelizaveta
    Sykes, Kevin
    Lominska, Christopher
    Gan, Gregory
    Buchakjian, Marisa R.
    Harding, Brette
    Dooley, Laura
    Shinn, Justin
    Wood, C. Burton
    Rohde, Sarah
    Khaja, Sobia
    Abt, Nicholas B.
    Varvares, Mark
    Bur, Andres M.
    ORAL ONCOLOGY, 2023, 142
12345